A RuII Polypyridyl Alkyne Complex Based Metal-Organic Frameworks for Combined Photodynamic/Photothermal/Chemotherapy

Chemistry. 2020 Feb 3;26(7):1668-1675. doi: 10.1002/chem.201904704. Epub 2020 Jan 28.

Abstract

Despite drug delivery nanoplatforms receiving extensive attention, development of a simple, effective, and multifunctional theranostics nanoplatform still remains a challenge. Herein, a versatile nanoplatform based on a zirconium framework (UiO-66-N3 ) was synthesized, which demonstrated a combined photodynamic therapy (PDT), photothermal therapy (PTT), and chemotherapy (CT) for cancer treatment. A RuII polypyridyl alkyne complex (Ra) as a photosensitizer was modified into a nanoplatform by click reactions for the first time. When exposed to suitable light irradiation, the as-prepared multifunctional nanoplatform (UiO-Ra-DOX-CuS) not only demonstrated efficient 1 O2 generation, but also exhibited excellent photothermal conversion ability. In particular, the nanotherapeutic agent presented a dual-stimuli response; either acidic environment or NIR laser irradiation would trigger the drug release. The synergetic efficacy of UiO-Ra-DOX-CuS combined PDT, PTT, and CT, which was evaluated by cell experiments. Moreover, the design could promote the development of RuII polypyridyl alkyne complexes based multifunctional nanoparticles and multimodal cancer treatment.

Keywords: RuII polypyridyl complexes; click reactions; drug delivery; multimodal cancer treatment; nanoplatforms.

MeSH terms

  • Alkynes / pharmacology*
  • Combined Modality Therapy
  • Drug Delivery Systems
  • Drug Liberation
  • Drug Therapy, Combination
  • Humans
  • Metal-Organic Frameworks
  • Photochemotherapy
  • Photosensitizing Agents / chemistry
  • Photosensitizing Agents / pharmacology*
  • Ruthenium Compounds / chemistry*
  • Theranostic Nanomedicine

Substances

  • Alkynes
  • Metal-Organic Frameworks
  • Photosensitizing Agents
  • Ruthenium Compounds